Venus Remedies, 526953, VENUSREM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

418.59
18.95
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

381.07
N/A
0.85

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.63
12.13
0.07

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-3.95
7.87
-0.82

PAT CAGR (%)

10 Years
5 Years
3 Years

18.63
-
-11.22

P:E (Median)

8 Years
5 Years
3 Years

10.46
12.50
14.39

P:BV (Average)

8 Years
5 Years
3 Years

0.56
0.77
0.80

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.79
6.65
5.33

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 167.02 170.19 -1.86% 105.86 98.63 7.33% 175.16 148.53 17.93% 131.23 109.45 19.90%
Expenses 156.75 157.06 -0.20% 91.58 85.16 7.54% 153.88 127.50 20.69% 118.23 102.37 15.49%
EBITDA 10.27 13.13 -21.78% 14.28 13.47 6.01% 21.28 21.03 1.19% 13.00 7.08 83.62%
EBIDTM 6.15% 7.71% 13.49% 13.66% 12.15% 14.16% 9.91% 6.47%
Other Income 10.71 2.93 265.53% 1.56 2.06 -24.27% 3.91 3.24 20.68% 2.42 3.75 -35.47%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 6.17 6.21 -0.64% 5.76 7.32 -21.31% 5.72 8.06 -29.03% 6.30 6.97 -9.61%
PBT 14.81 9.85 50.36% 10.08 8.21 22.78% 19.47 16.21 20.11% 9.12 3.86 136.27%
Tax 5.55 4.40 26.14% 5.63 3.87 45.48% 6.96 8.67 -19.72% 0.93 1.25 -25.60%
PAT 9.26 5.45 69.91% 4.45 4.34 2.53% 12.51 7.54 65.92% 8.19 2.61 213.79%
PATM 5.54% 3.20% 4.20% 4.40% 7.14% 5.08% 6.24% 2.38%
EPS 6.91 4.07 69.78% 3.32 3.24 2.47% 9.34 5.63 65.90% 6.11 1.95 213.33%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 167.45 167.72 -0.16% 108.61 95.15 14.15% 195.16 155.64 25.39% 143.42 116.90 22.69%
Expenses 162.54 149.97 8.38% 97.35 84.75 14.87% 175.68 131.03 34.08% 131.38 108.80 20.75%
EBITDA 4.91 17.75 -72.34% 11.26 10.40 8.27% 19.48 24.61 -20.85% 12.04 8.10 48.64%
EBIDTM 2.93% 10.58% 10.37% 10.93% 9.98% 15.81% 8.39% 6.93%
Other Income 10.58 3.05 246.89% 1.59 2.26 -29.65% 3.92 3.41 14.96% 2.35 3.81 -38.32%
Interest 0.02 0.02 0.00% 0.02 0.06 -66.67% 0.02 0.00 0 0.07 0.15 -53.33%
Depreciation 6.40 6.44 -0.62% 5.98 7.55 -20.79% 5.91 8.29 -28.71% 6.54 7.22 -9.42%
PBT 9.07 14.34 -36.75% 6.85 5.05 35.64% 17.47 19.73 -11.45% 7.78 4.54 71.37%
Tax 5.56 4.40 26.36% 5.63 3.87 45.48% 6.96 8.67 -19.72% 0.93 1.25 -25.60%
PAT 3.51 9.94 -64.69% 1.22 1.18 3.39% 10.51 11.06 -4.97% 6.85 3.29 108.21%
PATM 2.10% 5.93% 1.12% 1.24% 5.39% 7.11% 4.78% 2.81%
EPS 2.63 7.43 -64.60% 0.91 0.88 3.41% 7.86 8.27 -4.96% 5.12 2.46 108.13%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 579.27 575.21 537.66 576.71 514.62 320.23 301.84 355.07 375.45 402.69 451.88 Net Sales Growth 9.96% 6.98% -6.77% 12.07% 60.70% 6.09% -14.99% -5.43% -6.76% -10.89% Cost Of Goods Sold 354.93 352.22 336.70 377.50 336.68 176.81 181.78 205.42 186.69 194.64 213.05 Gross Profit 224.34 223.00 200.96 199.22 177.94 143.42 120.06 149.65 188.76 208.05 238.82 GP Margin 38.73% 38.77% 37.38% 34.54% 34.58% 44.79% 39.78% 42.15% 50.28% 51.67% 52.85% Total Expenditure 520.44 514.32 476.14 507.89 467.76 277.16 267.55 311.51 328.16 323.14 364.94 Power & Fuel Cost - 4.99 4.17 3.78 3.39 3.41 3.50 3.02 3.08 2.90 3.28 % Of Sales - 0.87% 0.78% 0.66% 0.66% 1.06% 1.16% 0.85% 0.82% 0.72% 0.73% Employee Cost - 57.57 47.67 43.75 35.89 33.79 30.26 27.82 25.02 25.02 27.26 % Of Sales - 10.01% 8.87% 7.59% 6.97% 10.55% 10.03% 7.84% 6.66% 6.21% 6.03% Manufacturing Exp. - 22.40 25.46 25.48 20.63 18.35 18.98 34.28 75.01 58.94 73.60 % Of Sales - 3.89% 4.74% 4.42% 4.01% 5.73% 6.29% 9.65% 19.98% 14.64% 16.29% General & Admin Exp. - 21.23 18.63 15.01 13.76 15.22 9.79 11.86 12.20 10.85 14.36 % Of Sales - 3.69% 3.47% 2.60% 2.67% 4.75% 3.24% 3.34% 3.25% 2.69% 3.18% Selling & Distn. Exp. - 55.62 43.24 42.37 57.40 29.59 23.24 29.11 26.17 30.78 33.39 % Of Sales - 9.67% 8.04% 7.35% 11.15% 9.24% 7.70% 8.20% 6.97% 7.64% 7.39% Miscellaneous Exp. - 0.31 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 33.39 % Of Sales - 0.05% 0.05% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 58.83 60.89 61.52 68.82 46.86 43.07 34.29 43.56 47.29 79.55 86.94 EBITDA Margin 10.16% 10.59% 11.44% 11.93% 9.11% 13.45% 11.36% 12.27% 12.60% 19.75% 19.24% Other Income 18.60 11.32 10.17 8.43 17.76 3.58 4.51 1.19 3.10 0.67 0.55 Interest 0.00 0.00 0.00 0.00 12.73 13.05 25.15 35.44 35.87 36.74 40.70 Depreciation 23.95 25.55 31.37 32.58 34.28 31.05 32.95 32.73 39.32 40.47 44.74 PBT 53.48 46.65 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 Tax 19.07 16.15 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 Tax Rate 35.66% 34.62% 28.17% -9.67% -32.17% -31.31% 4.07% -13.49% 18.39% 60.13% -123.04% PAT 34.41 30.50 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 PAT before Minority Interest 34.41 30.50 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.94% 5.30% 5.39% 8.49% 10.55% -2.57% -8.98% -7.49% -5.39% 0.30% 1.01% PAT Growth 72.57% 5.32% -40.89% -9.73% - - - - - -73.63% EPS 25.68 22.76 21.61 36.56 40.50 -6.14 -20.23 -19.84 -15.10 0.90 3.40

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 614.64 601.45 555.51 600.18 548.12 339.33 321.89 372.41 400.04 418.27 463.99 Net Sales Growth 14.80% 8.27% -7.44% 9.50% 61.53% 5.42% -13.57% -6.91% -4.36% -9.85% Cost Of Goods Sold 374.58 354.69 330.99 386.98 340.79 174.31 181.95 205.08 227.07 238.51 268.94 Gross Profit 240.06 246.76 224.51 213.20 207.33 165.02 139.94 167.33 172.97 179.77 195.05 GP Margin 39.06% 41.03% 40.42% 35.52% 37.83% 48.63% 43.47% 44.93% 43.24% 42.98% 42.04% Total Expenditure 566.95 541.85 495.49 538.07 494.35 298.52 289.37 332.94 349.32 337.11 374.81 Power & Fuel Cost - 6.35 5.52 4.71 4.58 4.73 4.86 4.29 4.14 4.01 3.80 % Of Sales - 1.06% 0.99% 0.78% 0.84% 1.39% 1.51% 1.15% 1.03% 0.96% 0.82% Employee Cost - 66.95 57.05 52.33 46.02 46.02 42.10 39.31 34.27 32.44 32.36 % Of Sales - 11.13% 10.27% 8.72% 8.40% 13.56% 13.08% 10.56% 8.57% 7.76% 6.97% Manufacturing Exp. - 28.77 32.40 31.57 22.86 20.84 21.01 36.10 42.48 15.70 17.29 % Of Sales - 4.78% 5.83% 5.26% 4.17% 6.14% 6.53% 9.69% 10.62% 3.75% 3.73% General & Admin Exp. - 23.70 20.70 16.67 16.45 17.57 11.85 13.52 13.26 11.97 15.67 % Of Sales - 3.94% 3.73% 2.78% 3.00% 5.18% 3.68% 3.63% 3.31% 2.86% 3.38% Selling & Distn. Exp. - 61.09 48.58 45.80 63.64 35.05 27.60 34.65 28.10 34.48 36.75 % Of Sales - 10.16% 8.75% 7.63% 11.61% 10.33% 8.57% 9.30% 7.02% 8.24% 7.92% Miscellaneous Exp. - 0.31 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 36.75 % Of Sales - 0.05% 0.05% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 47.69 59.60 60.02 62.11 53.77 40.81 32.52 39.47 50.72 81.16 89.18 EBITDA Margin 7.76% 9.91% 10.80% 10.35% 9.81% 12.03% 10.10% 10.60% 12.68% 19.40% 19.22% Other Income 18.44 11.58 10.32 8.31 19.63 5.31 6.09 2.39 4.28 2.01 0.68 Interest 0.13 0.09 0.12 0.48 13.02 13.34 25.41 35.56 36.38 37.98 41.21 Depreciation 24.83 26.44 32.30 33.53 35.28 32.01 33.98 33.83 40.26 41.68 46.00 PBT 41.17 44.64 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 Tax 19.08 16.15 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 Tax Rate 46.34% 36.18% 29.95% -11.86% -27.21% -24.41% 3.87% -11.48% 21.07% 51.57% -94.72% PAT 22.09 28.49 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 PAT before Minority Interest 22.09 28.49 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.59% 4.74% 4.78% 6.78% 11.27% -2.95% -8.88% -8.24% -4.27% 0.41% 1.11% PAT Growth -13.27% 7.23% -34.75% -34.08% - - - - - -67.05% EPS 16.49 21.26 19.83 30.39 46.10 -7.46 -21.32 -22.90 -12.75 1.27 3.85

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 508.59 478.05 449.41 400.18 332.25 340.95 367.99 394.23 444.43 466.24 Share Capital 13.37 13.37 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 Total Reserves 495.22 464.68 436.05 374.09 319.91 328.61 355.65 381.89 432.99 454.79 Non-Current Liabilities 59.86 58.17 45.95 58.81 96.03 136.75 157.89 179.52 212.03 221.50 Secured Loans 0.00 0.00 0.00 0.00 23.92 60.88 86.02 112.69 134.55 150.91 Unsecured Loans 38.68 38.68 38.68 47.52 48.34 55.20 50.84 49.13 56.47 51.34 Long Term Provisions 10.26 8.85 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 Current Liabilities 72.81 72.67 82.61 87.82 215.98 254.46 222.61 193.71 177.59 157.06 Trade Payables 42.70 48.51 49.63 68.36 33.96 33.41 27.19 30.56 23.90 25.76 Other Current Liabilities 29.06 23.27 32.23 18.78 99.99 107.61 76.87 45.70 36.63 13.99 Short Term Borrowings 0.00 0.00 0.00 0.00 81.42 108.92 117.23 115.70 115.09 115.40 Short Term Provisions 1.05 0.89 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 Total Liabilities 641.26 608.89 577.97 546.81 644.26 732.16 748.49 767.46 834.05 844.80 Net Block 202.76 199.68 224.67 244.20 271.47 346.89 369.93 389.38 433.52 425.77 Gross Block 581.97 568.50 578.19 581.73 589.77 674.06 669.01 655.78 660.61 612.50 Accumulated Depreciation 379.21 368.82 353.52 337.53 318.30 327.17 299.08 266.40 227.09 186.73 Non Current Assets 280.26 290.70 313.57 333.08 360.33 478.57 499.96 517.54 575.53 618.72 Capital Work in Progress 21.08 26.10 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 Non Current Investment 0.16 0.14 0.14 0.14 0.14 0.14 0.14 28.74 28.74 28.74 Long Term Loans & Adv. 51.76 62.55 61.96 62.34 64.08 66.78 65.13 33.17 32.90 85.91 Other Non Current Assets 4.50 2.23 1.57 1.29 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 361.00 318.19 264.41 213.74 283.94 253.59 248.53 249.93 258.53 226.08 Current Investments 19.09 20.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 117.81 113.60 125.63 119.69 136.44 140.94 135.98 139.69 137.69 140.44 Sundry Debtors 89.54 84.92 30.41 16.44 29.78 31.39 44.15 41.91 53.88 59.37 Cash & Bank 67.64 53.30 49.97 30.24 1.44 1.28 3.64 3.15 3.04 3.52 Other Current Assets 66.91 1.78 5.25 5.70 116.28 79.98 64.77 65.18 63.91 22.76 Short Term Loans & Adv. 65.59 44.46 53.15 41.66 60.56 74.83 59.93 65.18 63.91 22.76 Net Current Assets 288.18 245.53 181.80 125.92 67.96 -0.87 25.93 56.22 80.94 69.02 Total Assets 641.26 608.89 577.98 546.82 644.27 732.16 748.49 767.47 834.06 844.80

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 487.55 460.34 440.45 400.28 323.37 332.52 361.91 388.67 437.62 456.68 Share Capital 13.37 13.37 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 Total Reserves 474.18 446.97 427.08 374.19 311.03 320.18 349.57 376.33 426.18 445.24 Non-Current Liabilities 59.86 58.17 45.95 58.12 95.82 136.68 158.47 179.52 212.05 221.55 Secured Loans 0.00 0.00 0.00 0.09 24.19 61.29 86.60 112.69 134.57 150.95 Unsecured Loans 38.68 38.68 38.68 46.74 47.87 54.73 50.84 49.13 56.47 51.34 Long Term Provisions 10.26 8.85 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 Current Liabilities 79.42 82.57 92.74 97.45 224.58 263.62 230.38 196.81 193.14 162.83 Trade Payables 44.14 50.84 50.17 71.36 36.70 36.00 29.33 29.73 25.14 29.56 Other Current Liabilities 31.57 27.23 37.76 21.10 101.70 110.30 78.47 46.16 42.71 15.96 Short Term Borrowings 2.65 3.61 4.06 4.30 85.58 112.80 121.26 119.16 123.32 115.40 Short Term Provisions 1.05 0.89 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 Total Liabilities 626.83 601.08 579.14 555.85 643.77 732.82 750.76 765.00 842.81 841.06 Net Block 218.53 215.96 240.94 261.68 289.37 364.45 389.20 406.18 452.48 443.65 Gross Block 617.51 603.75 612.50 616.32 623.96 707.02 702.77 686.50 679.57 641.12 Accumulated Depreciation 398.98 387.78 371.57 354.63 334.59 342.57 313.57 280.32 227.09 197.47 Non Current Assets 267.30 278.25 301.10 321.82 349.77 467.39 490.50 505.60 565.75 607.85 Capital Work in Progress 21.08 26.10 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 Non Current Investment 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 23.16 33.95 33.36 35.03 35.77 38.18 36.53 33.17 32.90 85.91 Other Non Current Assets 4.50 2.23 1.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 359.52 322.83 278.04 234.03 294.00 265.43 260.27 259.41 277.07 233.21 Current Investments 19.09 20.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 121.69 119.94 125.64 119.99 141.12 142.73 138.17 140.60 143.29 142.87 Sundry Debtors 80.50 76.66 38.60 32.04 30.69 38.04 47.27 47.29 61.59 63.22 Cash & Bank 68.09 54.45 50.40 31.42 2.13 2.81 3.98 3.56 7.07 3.62 Other Current Assets 70.15 1.78 5.01 5.70 120.06 81.85 70.84 67.96 65.12 23.51 Short Term Loans & Adv. 68.83 49.87 58.39 44.88 64.34 76.70 66.00 67.96 65.12 23.51 Net Current Assets 280.11 240.26 185.30 136.59 69.43 1.81 29.88 62.59 83.93 70.38 Total Assets 626.82 601.08 579.14 555.85 643.77 732.82 750.77 765.01 842.82 841.06

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 35.38 28.05 41.00 132.34 77.75 43.65 51.58 61.77 41.91 66.76 PBT 46.65 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 Adjustment 19.36 22.25 24.83 21.59 40.39 59.20 64.73 69.30 53.72 81.90 Changes in Working Capital -15.15 -34.53 -28.50 69.69 20.37 3.75 10.27 17.27 -14.82 -17.18 Cash after chg. in Working capital 50.87 28.05 41.00 108.89 63.31 43.65 51.58 61.77 41.91 66.76 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -15.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -6.94 -50.81 -16.75 55.98 -4.64 -11.27 -11.48 -18.06 3.20 -67.15 Net Fixed Assets -8.45 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 Net Investments 1.02 -20.13 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 Others 0.49 -39.50 -20.17 48.42 -129.06 -6.22 -28.34 -37.01 53.38 0.24 Cash from Financing Activity 0.00 0.00 -9.13 -161.88 -72.35 -34.74 -39.61 -43.60 -45.59 -0.47 Net Cash Inflow / Outflow 28.44 -22.76 15.12 26.45 0.76 -2.36 0.49 0.11 -0.48 -0.86 Opening Cash & Equivalents 20.07 42.83 27.70 0.00 0.50 3.64 3.15 3.04 3.52 4.38 Closing Cash & Equivalent 48.51 20.07 42.83 26.45 1.26 1.28 3.64 3.15 3.04 3.52

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 37.29 36.63 41.10 131.84 77.60 45.33 31.19 58.93 46.88 67.80 PBT 44.64 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 Adjustment 20.23 23.33 26.33 21.89 41.56 60.72 66.24 70.61 56.41 83.56 Changes in Working Capital -12.11 -24.63 -21.64 61.39 20.82 5.37 -7.52 9.96 -13.04 -18.40 Cash after chg. in Working capital 52.77 36.63 41.10 108.39 63.16 45.33 31.19 58.93 46.88 67.80 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -15.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.21 -50.83 -16.73 56.49 -4.75 -11.33 -11.48 -18.32 2.92 -67.18 Net Fixed Assets -8.45 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 Net Investments 1.02 -20.13 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 Others 0.22 -39.52 -20.15 48.93 -129.17 -6.28 -28.34 -37.27 53.10 0.21 Cash from Financing Activity -1.08 -0.57 -9.48 -162.24 -73.00 -35.17 -39.23 -44.13 -46.35 -1.42 Net Cash Inflow / Outflow 28.99 -14.77 14.90 26.09 -0.15 -1.17 -19.52 -3.51 3.46 -0.79 Opening Cash & Equivalents 21.21 43.26 28.88 1.94 2.03 3.98 0.00 7.07 3.62 4.41 Closing Cash & Equivalent 48.96 21.21 43.26 28.88 1.94 2.81 -19.52 3.56 7.07 3.62

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 380.48 357.63 336.21 313.10 269.21 276.25 298.16 319.42 388.42 407.48 ROA 4.88% 4.88% 8.71% 9.11% -1.20% -3.66% -3.51% -2.53% 0.14% 0.54% ROE 6.18% 6.25% 11.72% 15.10% -2.44% -7.65% -6.98% -4.83% 0.26% 0.97% ROCE 8.77% 8.03% 9.55% 10.80% 1.15% -0.48% 1.75% 1.50% 5.11% 5.55% Fixed Asset Turnover 1.00 0.94 0.99 0.88 0.51 0.45 0.54 0.57 0.63 0.77 Receivable days 55.35 39.15 14.83 16.39 34.86 45.68 44.23 46.56 51.33 49.34 Inventory Days 73.42 81.20 77.63 90.83 158.08 167.43 141.69 134.83 126.05 113.85 Payable days 47.26 53.20 57.04 55.46 42.49 37.63 31.43 27.90 25.33 24.89 Cash Conversion Cycle 81.51 67.15 35.41 51.76 150.45 175.48 154.49 153.50 152.04 138.30 Total Debt/Equity 0.08 0.08 0.09 0.12 0.65 0.86 0.82 0.78 0.74 0.68 Interest Cover 0.00 0.00 0.00 4.23 0.52 -0.12 0.34 0.31 1.08 1.05

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 364.74 344.38 329.50 313.18 262.01 269.42 293.23 314.92 382.47 399.13 ROA 4.64% 4.50% 7.18% 10.30% -1.45% -3.85% -4.05% -2.12% 0.20% 0.62% ROE 6.01% 5.90% 9.85% 17.40% -3.05% -8.23% -8.18% -4.13% 0.38% 1.12% ROCE 8.67% 7.72% 7.89% 12.37% 0.90% -0.67% 1.17% 2.00% 5.35% 5.74% Fixed Asset Turnover 0.99 0.91 0.98 0.88 0.51 0.46 0.54 0.59 0.63 0.76 Receivable days 47.69 37.87 21.48 20.89 36.97 48.37 46.34 49.67 54.45 50.42 Inventory Days 73.32 80.68 74.69 86.94 152.66 159.26 136.61 129.51 124.86 112.15 Payable days 48.87 55.69 57.31 57.86 42.82 37.91 30.30 26.74 26.74 27.25 Cash Conversion Cycle 72.13 62.86 38.86 49.96 146.80 169.72 152.65 152.44 152.57 135.32 Total Debt/Equity 0.08 0.09 0.10 0.13 0.68 0.90 0.85 0.80 0.77 0.70 Interest Cover 477.45 322.44 76.69 4.73 0.40 -0.17 0.23 0.41 1.09 1.06

Top Investors:

mc jain infoservices private limited

pradeep kumar jain

k.b.shekar

acadian emerging markets micro-cap equity master fund

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Venus Remedies secures Marketing Authorization in Philippines
6th Dec 2024, 15:51 PM

This authorization marks a significant milestone in the company's journey to strengthen its presence in the high-growth Southeast Asian pharmaceutical market
Read More
Venus Remedies gets nod to establish wholly owned subsidiary in Hungary
30th Nov 2024, 15:17 PM

The Board of Directors of the company at their meeting held on November 29, 2024 approved the same
Read More
Venus Remedies secures Malaysian PIC/S GMP approval for pre-filled syringe facility
5th Nov 2024, 10:44 AM

This marks the first PIC/S GMP accreditation for Venus Remedies' PFS facility
Read More
Venus Remedies - Quarterly Results
29th Oct 2024, 21:59 PM

Read More

Venus Remedies Ltd.

Pharmaceuticals & Drugs

BSE: 526953 | NSE: VENUSREM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Venus Remedies Ltd.

Pharmaceuticals & Drugs

BSE: 526953 | NSE: VENUSREM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: